Monday July 16, 2018
Home India Pakistan Expl...

Pakistan Exploits Situation In Jammu & Kashmir: India

India has accused Pakistan of cynically exploiting the situation in Jammu and Kashmir at the General Assembly

0
//
11
Pakistan Exploits Situation In Jammu & Kashmir: India
Pakistan Exploits Situation In Jammu & Kashmir: India. flickr
Republish
Reprint

India has accused Pakistan of cynically exploiting the situation in Jammu and Kashmir at the General Assembly while it was discussing an important issue.

“Such cynical attempts have failed in the past and do not find any resonance in this body,” Sandeep Kumar Bayyapu, a First Secretary in India’s UN Mission, said on Monday.

He was replying to a reference to Kashmir made by Pakistan’s Permanent Representative Maleeha Lodhi during a debate on the Right to Protect People against crimes against humanity.

“While we are having this serious debate for the first time in a decade on an issue that is of importance to all of us, we have witnessed that one delegation has, yet again, misused this platform to make an unwarranted reference to the situation in the Indian state of Jammu and Kashmir,” Bayyapu said.

“I would like to place on record and reiterate that the state of Jammu and Kashmir is an integral and inalienable part of India. No amount of empty rhetoric from Pakistan will change this reality,” he added.

Lodhi had said that many of the victims of killings and “mass-blinding” are “in Indian-occupied Jammu and Kashmir” and that they “have the further indignity of living under an illegal and alien occupation”.

Pakistan's Permanent Representative Maleeha Lodhi
Pakistan’s Permanent Representative Maleeha Lodhi. flickr

“Against this backdrop, calls for accountability would invariably smack of double standards and selectivity, especially when egregious crimes including killings and mass-blinding are being committed in full view of the international community,” she said.

However, Lodhi also said: “At its core, the responsibility to protect, is not a license to intervene in external situations, but, is instead, a universal principle of ‘non-indifference’, in keeping with historical context and cultural norms of respective settings.”

Also read: Women-Driven Rickshaw Program Creating Sensation in Pakistan

“We should also be mindful that the notion of ‘Responsibility to Protect’ does not become a mere re-enactment of the discredited ‘humanitarian interventions’ of the past,” she added. (IANS)

Click here for reuse options!
Copyright 2018 NewsGram

Next Story

Cepheid to Establish Manufacturing Unit for TB Diagnostics in India

Rifampicin is a drug commonly used in treating TB bacteria in first line of treatment

0
The GeneXpert Edge is developed specifically for near-patient testing, to help support a one visit test-and-treat approach.
The GeneXpert Edge is developed specifically for near-patient testing, to help support a one visit test-and-treat approach. (IANS)

Expanding its footprint in India, US-based molecular diagnostics company Cepheid Inc on Thursday announced its plans to establish a manufacturing unit in the country to improve Tuberculosis (TB) diagnostics.

Cepheid’s GeneXpert MTB/RIF test is a closed-cartridge-based system that is easy to operate by minimally trained staff and gives results in approximately two hours, speeding the conventional backlog that used to exist in traditional diagnostic methods.

The new manufacturing unit would produce MTB/RIF test cartridges, contribute to the government’s “Make in India” initiative and thus bringing the company’s global expertise in TB diagnostics to India, the company said in a statement.

As part of the plan, Cepheid also unveiled its latest portable, easy-to-use TB-testing system — the GeneXpert Edge — which is expected to be available in India later this year, the company said.

The GeneXpert Edge is developed specifically for near-patient testing, to help support a one visit test-and-treat approach.

“Cepheid recognises the need for technological advancement and is committed to contributing significantly to India’s goal of TB eradication,” said Peter Farrell, Executive Vice President, Worldwide Commercial Operations, Cepheid.

Cepheid's Xpert MTB/RIF test has the potential to detect Mycobacterium tuberculosis(MTB)
Cepheid’s Xpert MTB/RIF test has the potential to detect Mycobacterium tuberculosis(MTB).

“We are hopeful that GeneXpert Edge will help eliminate delays in TB diagnostics by providing definitive results within hours and facilitating fast and easy last-mile delivery even in the remote villages of India,” he added.

India has nearly one-fourth of the global TB patients and an estimated 4.8 lakh lives are lost every year due to delayed diagnosis and inadequate treatment and there are above 2.5 million new cases of TB every year. The country aims to eradicate TB by 2025.

Approved by the World Health Organisation (WHO) in 2010, more than 1,200 Cepheid’s GeneXpert Systems have been installed in the last two years at various Revised National Tuberculosis Control Programme (RNTCP) sites in the country and more than 2.5 million cartridges were supplied last year at various centres of Central TB Division (CTD).

Also Read: Fruit Bats Identified As Source Of Nipah Virus Outbreak in Kerala

Cepheid’s Xpert MTB/RIF test has the potential to detect Mycobacterium tuberculosis(MTB) and rifampicin-resistance mutations, which are markers for MDR-TB strains in under two hours.

Rifampicin is a drug commonly used in treating TB bacteria in first line of treatment.

Xpert MTB/RIF tests also have excellent negative predictive value, which allows clinicians to manage TB-negative patients more effectively to prevent unnecessary and costly respiratory isolations. (IANS)